4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      GC1qR Cleavage by Caspase-1 Drives Aerobic Glycolysis in Tumor Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Self-sustained cell proliferation constitutes one hallmark of cancer enabled by aerobic glycolysis which is characterized by imbalanced glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) activity, named the Warburg effect. The C1q binding protein ( C1QBP; gC1qR) is pivotal for mitochondrial protein translation and thus OXPHOS activity. Due to its fundamental role in balancing OXPHOS and glycolysis, c1qbp −/− mice display embryonic lethality, while gC1qR is excessively up-regulated in cancer. Although gC1qR encompasses an N-terminal mitochondrial leader it is also located in other cellular compartments. Hence, we aimed to investigate mechanisms regulating gC1qR cellular localization and its impact on tumor cell metabolism. We identified two caspase-1 cleavage sites in human gC1qR. GC1qR cleavage by active caspase-1 was unraveled as a cellular mechanism that prevents mitochondrial gC1qR import, thereby enabling aerobic glycolysis and enhanced cell proliferation. Ex vivo, tumor grading correlated with non-mitochondrial-located gC1qR as well as with caspase-1 activation in colorectal carcinoma patients. Together, active caspase-1 cleaves gC1qR and boosts aerobic glycolysis in tumor cells.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: found

          Hallmarks of Cancer: The Next Generation

          The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer. Copyright © 2011 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Understanding the Warburg effect: the metabolic requirements of cell proliferation.

            In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect." Aerobic glycolysis is an inefficient way to generate adenosine 5'-triphosphate (ATP), however, and the advantage it confers to cancer cells has been unclear. Here we propose that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell. Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-associated mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP production. A better understanding of the mechanistic links between cellular metabolism and growth control may ultimately lead to better treatments for human cancer.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              On the Origin of Cancer Cells

              O WARBURG (1956)
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                30 September 2020
                2020
                : 10
                : 575854
                Affiliations
                [1] 1Institute of Nutritional Medicine, University Hospital Schleswig-Holstein , Lübeck, Germany
                [2] 2Institute of Pathology, University Hospital Schleswig-Holstein , Lübeck, Germany
                [3] 3Pathology of the Research Center Borstel, Leibniz Lung Center , Borstel, Germany
                [4] 4Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD, United States
                [5] 5Faculty of Life Sciences and Medicine, School of Immunology and Microbial Sciences, King's College London , London, United Kingdom
                [6] 6Institute for Systemic Inflammation Research, University of Lübeck , Lübeck, Germany
                [7] 7Department of Medicine, Stony Brook University , Stony Brook, NY, United States
                [8] 81st Department of Medicine, Division of Nutritional Medicine, University Hospital Schleswig-Holstein , Lübeck, Germany
                Author notes

                Edited by: Monica Montopoli, University of Padua, Italy

                Reviewed by: Brandon Faubert, University of Texas Southwestern Medical Center, United States; Maria Letizia Taddei, University of Florence, Italy

                *Correspondence: Stefanie Derer Stefanie.Derer@ 123456uksh.de

                This article was submitted to Cancer Metabolism, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2020.575854
                7556196
                33102234
                2299004f-e20b-4b8f-921c-f74fb2153c94
                Copyright © 2020 Sünderhauf, Raschdorf, Hicken, Schlichting, Fetzer, Brethack, Perner, Kemper, Ghebrehiwet, Sina and Derer.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 24 June 2020
                : 28 August 2020
                Page count
                Figures: 7, Tables: 1, Equations: 0, References: 34, Pages: 16, Words: 8895
                Funding
                Funded by: Deutsche Forschungsgemeinschaft 10.13039/501100001659
                Award ID: DE 1874/1-2
                Categories
                Oncology
                Original Research

                Oncology & Radiotherapy
                aerobic glycolysis,gc1qr,inflammasome,mitochondria,oxphos,caspase-1,c1qbp,p32/habp1
                Oncology & Radiotherapy
                aerobic glycolysis, gc1qr, inflammasome, mitochondria, oxphos, caspase-1, c1qbp, p32/habp1

                Comments

                Comment on this article